Page 2 - Tyr Pharma Company News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Tyr pharma company. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Tyr Pharma Company Today - Breaking & Trending Today

55,857 Shares in aTyr Pharma, Inc. (NASDAQ:LIFE) Bought by Pale Fire Capital SE

Pale Fire Capital SE bought a new stake in aTyr Pharma, Inc. (NASDAQ:LIFE – Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 55,857 shares of the biotechnology company’s stock, valued at approximately $88,000. Pale Fire Capital […] ....

United States , Atyr Pharma Inc , Tyr Pharma Company Profile , Securities Exchange Commission , Topco Ltd , Sigma Securities , Royal Bank , Pale Fire Capital , Tyr Pharma , Free Report , Fire Capital , State Street Corp , Street Corp , Tyr Pharma Price , Tyr Pharma Company , Tyr Pharma Daily , Atyr Pharma , Nasdaq Life , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

aTyr Pharma, Inc. (NASDAQ:LIFE) Receives $20.75 Consensus PT from Brokerages

Shares of aTyr Pharma, Inc. (NASDAQ:LIFE – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the six analysts that are covering the company, MarketBeat reports. One equities research analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 1-year […] ....

United States , Alyeska Investment Group , Tyr Pharma Company Profile , Stonepine Capital Management , Atyr Pharma Inc , Samsara Biocapital , Blackrock Inc , Tyr Pharma , Get Free Report , Capital Management , Tyr Pharma Price , Tyr Pharma Company , Get Free , Tyr Pharma Daily , Atyr Pharma , Nasdaq Life ,

Brokerages Set aTyr Pharma, Inc. (NASDAQ:LIFE) Target Price at $20.75

ATyr Pharma, Inc. (NASDAQ:LIFE – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the six brokerages that are covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 1 year price […] ....

United States , Sigma Securities , American Century Companies Inc , Atyr Pharma Inc , Tyr Pharma Company Profile , Squarepoint Ops , Virtu Financial , Tyr Pharma , Get Free Report , Street Group , American Century Companies , Century Companies , Tyr Pharma Price , Tyr Pharma Company , Get Free , Tyr Pharma Daily , Atyr Pharma , Nasdaq Life ,

aTyr Pharma (NASDAQ:LIFE) Downgraded by StockNews.com

StockNews.com lowered shares of aTyr Pharma (NASDAQ:LIFE – Free Report) from a hold rating to a sell rating in a research note released on Saturday morning. Separately, HC Wainwright reaffirmed a buy rating and issued a $35.00 price objective on shares of aTyr Pharma in a research report on Thursday, September 21st. One research analyst […] ....

United States , Tyr Pharma Company Profile , Capital Partners , Sigma Securities , Squarepoint Ops , American Century Companies Inc , Atyr Pharma Inc , Tyr Pharma , Free Report , Moderate Buy , Tyr Pharma Stock , Get Free Report , Street Group , Century Companies , Tyr Pharma Company , Tyr Pharma Daily , Atyr Pharma , Nasdaq Life , Stocknews Com ,

aTyr Pharma, Inc. (NASDAQ:LIFE) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

ATyr Pharma, Inc. (NASDAQ:LIFE – Get Free Report) has earned an average recommendation of “Moderate Buy” from the six research firms that are covering the firm, MarketBeat reports. One analyst has rated the stock with a hold rating and five have given a buy rating to the company. The average 12 month price objective among […] ....

United States , Tyr Pharma Company Profile , Capital Partners , York Mellon Corp , Hermes Inc , Virtu Financial , Atyr Pharma Inc , Charles Schwab Investment Management Inc , Tyr Pharma , Get Free Report , Tyr Pharma Stock , New York Mellon Corp , Schwab Investment Management , Tyr Pharma Company , Get Free , Tyr Pharma Daily , Atyr Pharma , Nasdaq Life ,